New Edge Advisors, LLC Horizon Therapeutics Public LTD CO Transaction History

New Edge Advisors, LLC

$15 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $44,936 - $52,545	-454 Reduced 36.2%	800 $92,000
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $19,846 - $23,150	206 Added 19.66%	1,254 $128,000
Q1 2023 May 12, 2023	SELL	$107.32 - $113.5 $47,864 - $50,621	-446 Reduced 29.85%	1,048 $114,000
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $344,704 - $628,745	-5,525 Reduced 78.71%	1,494 $170,000
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $53,617 - $77,049	-910 Reduced 11.48%	7,019 $434,000
Q2 2022 Aug 09, 2022	BUY	$79.4 - $116.36 $629,562 - $922,618	7,929 New	7,929 $632,000
Q1 2022 May 13, 2022	SELL	$86.42 - $109.81 $720,742 - $915,815	-8,340 Closed	0 $0
Q4 2021 Feb 17, 2022	SELL	$98.56 - $119.91 $247,385 - $300,974	-2,510 Reduced 23.13%	8,340 $899,000
Q3 2021 Oct 29, 2021	BUY	$91.91 - $110.37 $39,061 - $46,907	425 Added 4.08%	10,850 $1.19 Million
Q2 2021 Jul 22, 2021	BUY	$86.24 - $95.92 $541,156 - $601,898	6,275 Added 151.2%	10,425 $976,000
Q1 2021 Apr 26, 2021	BUY	$71.83 - $95.48 $2,083 - $2,768	29 Added 0.7%	4,150 $382,000
Q4 2020 Jan 27, 2021	BUY	$67.0 - $84.39 $37,855 - $47,680	565 Added 15.89%	4,121 $301,000
Q3 2020 Nov 03, 2020	BUY	$55.23 - $79.93 $196,397 - $284,231	3,556 New	3,556 $276,000
Q1 2020 May 04, 2020	SELL	$24.87 - $38.56 $205,252 - $318,235	-8,253 Closed	0 $0
Q4 2019 Jan 31, 2020	SELL	$25.43 - $36.67 $9,587 - $13,824	-377 Reduced 4.37%	8,253 $298,000
Q3 2019 Nov 06, 2019	SELL	$23.0 - $27.97 $21,620 - $26,291	-940 Reduced 9.82%	8,630 $235,000
Q2 2019 Aug 05, 2019	BUY	$22.81 - $28.48 $218,291 - $272,553	9,570 New	9,570 $230,000

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.

Account